Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (16691)	2/29/2004 4:19:28 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

ACNE!!!!!!!!!!!!!! ACNE!!!!!!!!!!!!!!! ACNE!!!!!!!!!!>>>>>http://www.prohostonline.com/ImpactingNews/IN%201%2022.pdf

To: Robert K. who wrote (16691)	2/29/2004 11:23:00 PM
From: Bluegreen	Respond to of 17367

WELL WELL WELL!!!!!!!!!!!!! Just think of POSSIBLE off label uses of Raptiva in MILD TO MODERATE Psoriasis. Off label uses could maybe EXCEED labeled uses IF this article is correct in MIX AND MATCH COMBINATIONAL THERAPIES!!!!! NOTICE THE MENTION OF NEW BIOLOGICS AND AUTHOR'S NAMES!!!!!>>>>>>>>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14988684&dopt=Abstract

To: Robert K. who wrote (16691)	2/29/2004 11:31:18 PM
From: Bluegreen	Respond to of 17367

So, Bob, you have a patient controlled pretty well with a conventional therapy that has MILD Psoriasis BUT a few RESISTANT BOTHERSOME LESIONS. The patient is JUST NOT SATISFIED!!!!! Why not add one of the new biologics off label in a light dose or intermittent dose that is AFFORDABLE OFF LABEL?????